Outlook Therapeutics director’s firm buys $5m in common stock
Outlook Therapeutics director’s firm buys $5m in common stock
Outlook Therapeutics director’s firm buys $5m in common stock
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.